English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

The Familial Hypercholesterolemia (FH) is the most common co-autosomal dominant inherited condition in man. It is mainly caused by mutations in the following three genes: the encoding: the receiver of low-density lipoprotein LDL-C (most common), or apolipoprotein B100 proprotein convertase subutilisina / kexina type 9 (PCSK-9). The resulting chronic elevations in LDL-C levels entail the development of early atherosclerotic cardiovascular disease. The overall estimated prevalence for heterozygous HF ranges from about 1 / 200-250 1/500 and homozygous FH is 1/1 000 000. The childhood is the ideal period of life to discriminate between dyslipidemias FH and not FH. serum LDL-C≥190 mg / dL (2 measures up to 3 months), or LDL-C≥160 mg / dL with a family history of premature coronary disease or high levels of cholesterol increased basal in a parent or LDL -C≥130 mg / dL with positive genetic diagnosis in families may be used as the phenotypic criteria for diagnosis. It is the aim of this study make the early diagnosis of HF in a population sample of children, adolescents and adults Brazilian city of Campinas / SP.

FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN CHILDREN AND ADOLESCENTS: OPTIMIZATION OF DETECTION FOR EARLY TREATMENT